Malatesta Michael F 4

What Happened

• Michael F. Malatesta, Chief Financial Officer of Select Medical Holdings Corp (SEM), reported the disposition of 238,057 SEM shares on June 30, 2026. The transaction is coded as "Other acquisition or disposition (J)" and shows a $0.00 per-share price (total proceeds $0), indicating the shares were transferred as part of a merger transaction rather than sold for cash.

Key Details

• Transaction date: 2026-06-30; Form 4 filed: 2026-07-01 (covers the 6/30/2026 reporting period).
• Shares disposed: 238,057; reported price: $0.00; reported value: $0.
• Transaction code: J — made in connection with a merger or acquisition.
• Footnotes: F1/F2 state the disposition occurred under the Merger Agreement (filed 3/3/2026). Immediately prior to the merger's effective time, Malatesta contributed 79,723 common shares and 158,334 restricted shares to Parent, received Parent common shares, which were then exchanged for interests in Stallion Group Parent, LP.
• Post-transaction holding: The filing indicates these 238,057 SEM shares were converted/exchanged under the merger; the report implies no remaining SEM common shares from this lot.

Context

• This was a merger-related conversion/exchange, not an open-market sale; no cash changed hands on the reported disposition, so it should not be read as a routine insider sell signal. The reporting person received ownership interests in the acquiring parent (Stallion Group Parent, LP) as described in the footnotes.